CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma

Clinical trial NCT03672253 · UNKNOWN

Trial details

NCT number: NCT03672253
Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma in Relapse Multiple Myeloma Progression

Start date: 2018-07-26
Primary completion: 2020-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.